Share-based Payment Arrangement, Expense in USD of Oncotelic Therapeutics, Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2010 to Q1 2025.
  • Oncotelic Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $0.000.
  • Oncotelic Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $0.000.
  • Oncotelic Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $0.000, a 100% decline from 2022.
  • Oncotelic Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $900K, unchanged from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Oncotelic Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $0 $0 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q1 2024 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q1 2023 $600K $0 -$300K -100% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $900K $275K 01 Oct 2022 31 Dec 2022 10-K 12 Apr 2024
Q3 2022 $300K $0 0% 01 Jul 2022 30 Sep 2022 10-Q 18 Nov 2022
Q2 2022 $25K 01 Apr 2022 30 Jun 2022 10-Q 22 Aug 2022
Q1 2022 $300K +$300K 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023
Q3 2021 $300K 01 Jul 2021 30 Sep 2021 10-Q 18 Nov 2022
Q1 2021 $0 -$2.1M -100% 01 Jan 2021 31 Mar 2021 10-Q 22 Nov 2021
Q1 2020 $2.1M +$1.76M +516% 01 Jan 2020 31 Mar 2020 10-Q 24 May 2021
Q1 2020 $2.1M +$1.76M +516% 01 Feb 2020 29 Feb 2020 10-Q 22 Nov 2021
Q1 2019 $341K +$157K +85.3% 01 Apr 2019 30 Apr 2019 10-K 15 Apr 2021
Q1 2019 $212K +$28K +15.2% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2019
Q1 2018 $184K 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q3 2013 $200K 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2013

Oncotelic Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 $0 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 $0 -$900K -100% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 $900K $0 0% 01 Jan 2022 31 Dec 2022 10-K 12 Apr 2024
2021 $900K +$900K 01 Jan 2021 31 Dec 2021 10-K/A 20 Apr 2023
2020 $0 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022
2018 $744K -$91K -10.9% 01 Jan 2018 31 Dec 2018 10-K 10 Apr 2019
2017 $835K +$31K +3.86% 01 Jan 2017 31 Dec 2017 10-K 10 Apr 2019
2016 $804K -$2K -0.25% 01 Jan 2016 31 Dec 2016 10-K 17 Apr 2018
2015 $806K +$392K +94.7% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017
2014 $414K -$265K -39% 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016
2013 $679K +$168K +32.9% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2015
2012 $511K -$340K -40% 01 Jan 2012 31 Dec 2012 10-K 30 Mar 2015
2011 $851K +$1.54M 01 Jan 2011 31 Dec 2011 10-K 20 Mar 2014
2010 -$687K 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.